What is it about?
We assessed the potential clinical utility of DNA arrays in rapid diagnosis of AML.
Featured Image
Why is it important?
Good prognosis AML could be rapidly identified and included in specific protocols.
Perspectives
Read the Original
This page is a summary of: Feasibility of the AML profiler (Skyline™ Array) for patient risk stratification in a multicentre trial: a preliminary comparison with the conventional approach, Hematological Oncology, May 2016, Wiley,
DOI: 10.1002/hon.2304.
You can read the full text:
Contributors
The following have contributed to this page